The estimated Net Worth of Mai Chan Yow is at least $73.1 Thousand dollars as of 20 February 2018. Mai Yow owns over 2,279 units of Standard BioTools Inc stock worth over $73,106 and over the last 13 years Mai sold FLDM stock worth over $0.
Mai has made over 20 trades of the Standard BioTools Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Mai exercised 2,279 units of FLDM stock worth $8,455 on 20 February 2018.
The largest trade Mai's ever made was exercising 40,000 units of Standard BioTools Inc stock on 19 September 2011 worth over $148,400. On average, Mai trades about 4,938 units every 57 days since 2011. As of 20 February 2018 Mai still owns at least 19,705 units of Standard BioTools Inc stock.
You can see the complete history of Mai Yow stock trades at the bottom of the page.
Mai's mailing address filed with the SEC is FLUIDIGM CORPORATION, 7000 SHORELINE COURT SUITE 100, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev..., and Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Standard BioTools Inc executives and other stock owners filed with the SEC include: